“…There have been fewer reports on the outcomes for CI for other genes, although some reports have described good performances in CI/EAS patients with associated SLC26A4 ( 25 , 39 ), OTOF ( 25 , 40 , 41 ) , MYO6 ( 8 , 42 ) , MYO15A ( 3 , 4 ) , TECTA ( 3 ) , CDH23 ( 2 ) , COCH ( 5 , 43 ) , MYH9 ( 44 , 45 ), and TMPRSS3 mutations ( 1 , 3 , 6 , 25 , 46 , 47 ). There have also been some reports describing poorer outcomes in patients with POU3F4 mutations, which are known to cause inner ear anomalies ( 48 – 51 ).…”